Esperion Therapeutics
ESPR
ESPR
185 hedge funds and large institutions have $171M invested in Esperion Therapeutics in 2025 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 55 increasing their positions, 56 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
185
Holders Change
-3
Holders Change %
-1.6%
% of All Funds
2.51%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
26
Increased
55
Reduced
56
Closed
28
Calls
$496K
Puts
$1.36M
Net Calls
-$862K
Net Calls Change
-$1.96M
Top Buyers
| 1 |
PCM
PenderFund Capital Management
Vancouver,
British Columbia, Canada
|
+$10.8M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$5.23M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$1.6M |
| 4 |
TSC
Two Seas Capital
Rye,
New York
|
+$1.01M |
| 5 |
Squarepoint
New York
|
+$775K |
Top Sellers
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$19.5M |
| 2 |
CP
CenterBook Partners
Greenwich,
Connecticut
|
-$2.87M |
| 3 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
-$1.85M |
| 4 |
Goldman Sachs
New York
|
-$1.77M |
| 5 |
Two Sigma Advisers
New York
|
-$1.57M |
